Oscar Health price target raised to $27 from $24 at Wells Fargo

Wells Fargo analyst Stephen Baxter raised the firm’s price target on Oscar Health to $27 from $24 and keeps an Overweight rating on the shares. The firm notes Oscar Health’s “core” financial targets are higher than they initially appeared after clarifying tax rate impacts. As a result, Wells is making a handful of model changes and increasing its price target.